XML 46 R27.htm IDEA: XBRL DOCUMENT v3.25.0.1

Segment Disclosures

12 Months Ended

Dec. 31, 2024

Segment Disclosures [Abstract]

Segment Disclosures

Segment Disclosures

Our operations have one reportable segment engaged in the research and development and commercialization of oncology

treatments, which is consistent with the way we report information to our chief decision maker and Board of Directors.

The following geographic information reflects non-current assets by location:

Property and equipment			December 31, 2024						December 31, 2023
Canada			$	203					$	246
Rest of world			208						36
			$	411					$	282

Right-of-use-assets			December 31, 2024						December 31, 2023
Canada			$	74					$	111
Rest of world			827						254
			$	901					$	365

X

- Definition

The entire disclosure for operating segments.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 8
-IssueDate 2024-01-01
-Section Disclosure
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=8&code=ifrs-tx-2024-en-r&doctype=Standard&dita_xref=IFRS08_g20-24_TI
-URIDate 2024-03-27

+ Details

Name:	ifrs-full_DisclosureOfEntitysReportableSegmentsExplanatory
Namespace Prefix:	ifrs-full_
Data Type:	dtr-2022:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Segment Disclosures [Abstract]

+ References

No definition available.

+ Details

Name:	oncyf_SegmentDisclosuresAbstract
Namespace Prefix:	oncyf_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration